Clinical Trial: Centralized Pan-South African Survey on the Undertreatment of Hypercholesterolaemia

Study Status: Completed
Recruit Status: Completed
Study Type: Observational

Official Title: Centralized Pan-South African Survey on the Undertreatment of Hypercholesterolaemia.

Brief Summary: This is a multi-centre survey of patients who are currently on lipid lowering pharmacological treatment in South Africa.

Detailed Summary:
Sponsor: AstraZeneca

Current Primary Outcome: Proportion of patients on lipid-lowering pharmacological treatment reaching LDL-C goals according to NCEP ATP III/Updated 2004 NCEP ATP III

Original Primary Outcome: Same as current

Current Secondary Outcome:

  • Proportion of patients on lipid-lowering pharmacological treatment reaching LDL-C goals according to NCEP ATP III/Updated 2004 NCEP ATP III
  • Proportion of patients on lipid-lowering pharmacological treatment reaching LDL-C goals according to the Fourth Joint European Task Force Guidelines/South African Guidelines in primary/secondary prevention patients, patients with metabolic syndrome
  • Proportion of patients on lipid-lowering pharmacological treatment reaching the non HDL-C goals according to NCEP ATP III/Updated 2004 NCEP ATP III Guidelines


Original Secondary Outcome: Same as current

Information By: AstraZeneca

Dates:
Date Received: December 4, 2009
Date Started: November 2009
Date Completion:
Last Updated: April 14, 2011
Last Verified: April 2011